Regarding the treatment of cognitive impairment in patients with PD, most of the treatment trials for dementia in patients with PD have focused on the development of drugs which was developed for the treatment of cognitive symptoms in Alzheimer’s disease, including cholinesterase inhibitors and the N-methyl-D-aspartate receptor antagonist, memantine (Goldman and Weintraub, 2015). This evidence concerns the gene BCHE and Alzheimer disease.